Hydroxyurea dose for polycythemia vera

Jun 1, 2021 · Ferrari A, Carobbio A, Masciulli A, et al. Introduction Hydroxyurea (HU) is worldwide used in the current clinical practice as first line treatment in high risk patients with Polycythemia Vera (PV)

2024-03-28
    Micardis plus cough
  1. e
  2. It's the same procedure used for donating blood
  3. 72 g
  4. In this study, we investigated HU treatment patterns in patients
  5. Last updated on Aug 9, 2023
  6. Estimates showed
  7. et al
  8. The incidence of PV has been estimated as 0
  9. g
  10. Long-term efficacy and safety of recombinant interferon alpha-2 vs